Emily Birthisel reflects on the privilege and responsibility of helping medical device innovation move from an idea toward safe patient use.
Supporting a medical device trial is a nuanced, rewarding, strategic, and multidisciplinary responsibility that we are privileged to hold at Mobius Medical.
Groundbreaking innovation is happening every day at academic institutions, university spin-outs, growing scale-up companies, and large MedTech organisations.
Breakthroughs may begin in very different places, yet they almost always converge on the same requirement; proving that the device is safe, and performs as intended in humans.
At Mobius, we support device trials from many different innovators across a wide range of therapeutic areas, partnering with leading healthcare institutions and clinicians.
Device trials propel innovation toward commercial viability. However, many promising technologies never fully realise their potential due to fragmented development, limited clinical validation, or poorly aligned regulatory planning.
Supporting a device trial is where strategy meets impact. It creates the clinical evidence required to advance regulatory approval and ensures that innovation translates into accessible solutions for patients.
It means that we get to identify the best doctors, the best teams, the best departments and hospitals; to accelerate commercialisation of new Devices, and to facilitate pre-market access to new treatments, for patients who may have had no other options left.
It also means staying closely connected to the patient journey. We work alongside world-first innovators and clinical pioneers, understanding unmet needs, design refinements, procedural realities, and treatment successes. By listening to clinicians and observing how devices perform in practice, we help ensure new technologies are not only compliant; but truly optimised for the environments in which they will be used.
Supporting Device trials is an opportunity to bridge the gap between engineering, clinical practice and regulatory strategy, ultimately contributing to better treatments and improved patient outcomes.